Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I randomized, double blinded placebo-controlled, multiple dose study of PF-03709270 in healthy volunteers with or without co-administration of probenecid, in fed or fasted state

Trial Profile

A phase I randomized, double blinded placebo-controlled, multiple dose study of PF-03709270 in healthy volunteers with or without co-administration of probenecid, in fed or fasted state

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Oct 2018

At a glance

  • Drugs Sulopenem (Primary) ; Probenecid
  • Indications Intra-abdominal infections; Urinary tract infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 07 Oct 2018 Results presented at the IDWeek 2018
    • 20 Sep 2018 According to an Iterum Therapeutics media release, data will be presented in poster sessions at IDWeek 2018.
    • 24 Apr 2018 Results (n=63) presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top